Key result
Post-TAVR RVP burden ≥30% linked to ~145% higher risk of death or HF.
Why the study?
Patients receiving permanent pacemakers after TAVR have worse outcomes, but the risk factors for these adverse outcomes were not identified.
Does right ventricular pacing burden ≥30% increase the risk of heart failure readmission and death in patients with post-TAVR permanent pacemaker implantation?
Cohort (n=110)
No
Does right ventricular pacing burden ≥30% increase the risk of heart failure readmission and death in patients with post-TAVR permanent pacemaker implantation?
In patients requiring a permanent pacemaker after TAVR, a right ventricular pacing burden ≥30% at 1 year is associated with significantly increased risks of heart failure readmission and death.
AIMS: Patients who undergo permanent pacemaker (PPM) implantation after transcatheter aortic valve replacement (TAVR) have a worse outcome. The aim of this study was to identify risk factors of worse outcomes in patients with post-TAVR PPM implantation. METHODS AND RESULTS: This is a single-centre, retrospective study of consecutive patients who underwent post-TAVR PPM implantation from 11 March 2011 to 9 November 2019. Clinical outcomes were evaluated by landmark analysis with cut-off at 1 year after the PPM implantation. Of the 1389 patients underwent TAVR during the study duration and a total of 110 patients were included in the final analysis. Right ventricular pacing burden (RVPB) ≥ 30% at 1 year was associated with a higher likelihood of heart failure (HF) readmission [adjusted hazard ratio (aHR): 6.333; 95% confidence interval [CI]: 1.417-28.311; P = 0.016] and composite endpoint of overall death and/or HF (aHR: 2.453; 95% CI: 1.040-5.786; P = 0.040). The RVPB ≥30% at 1 year was associated with higher atrial fibrillation burden (24.1 ± 40.6% vs. 1.2 ± 5.3%; P = 0.013) and a decrease in left ventricular ejection fraction (-5.0 ± 9.8% vs. + 1.1 ± 7.9%; P = 0.005). The predicting factors of the RVPB ≥30% at 1 year were the presence of RVPB ≥40% at 1 month and the valve implantation depth measured from non-coronary cusp ≥4.0 mm (aHR: 57.808; 95% CI: 12.489-267.584; P < 0.001 and aHR: 6.817; 95% CI: 1.829-25.402; P = 0.004). CONCLUSIONS: The RVPB ≥30% at 1 year was associated with worse outcomes. Clinical benefit of minimal RV pacing algorithms and biventricular pacing needs to be investigated.
No takes yet. Share an insight, caveat, or question.
Tsushima et al. (2023) conducted a cohort in Post-transcatheter aortic valve replacement permanent pacemaker implantation (n=110). Right ventricular pacing burden ≥30% vs. Right ventricular pacing burden <30% was evaluated on Composite endpoint of overall death and/or heart failure (aHR 2.453, 95% CI 1.040-5.786, p=0.040). Right ventricular pacing burden ≥30% at 1 year post-TAVR pacemaker implantation was associated with an increased risk of death or heart failure (aHR 2.453; 95% CI 1.040-5.786; P=0.040).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: